Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0900
+0.0113
+(14.36%)
At close: February 24 at 3:50:43 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-279.6270
-106.7650
-656.6200
-235.4820
-14.2530
Investing Cash Flow
--
--
--
-2.7460
--
Financing Cash Flow
165
--
-225
1,395
125
End Cash Position
202.3580
279.1340
385.8990
1,267.5190
110.7470
Interest Paid Supplemental Data
--
--
17.5420
--
--
Capital Expenditure
--
--
--
-2.7460
--
Issuance of Capital Stock
--
--
150
--
--
Issuance of Debt
165
--
250
1,395
125
Repayment of Debt
--
--
-625
--
--
Free Cash Flow
-279.6270
-106.7650
-656.6200
-238.2280
-14.2530
12/31/2020 - 3/31/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HAVLF HAVN Life Sciences Inc.
0.0005
-95.00%
IVRN Innoveren Scientific Inc.
0.0004
+33.33%
CHRO Channel Therapeutics Corporation
1.7500
+4.17%
BTAX Biostax Corp.
0.0100
+42.86%
QUIA.ST Quia Pharma AB (publ)
0.0048
-2.04%
EPRX Eupraxia Pharmaceuticals Inc.
3.7630
+3.10%
PPBT.TA Purple Biotech Ltd
5.60
-1.75%
ALZCUR.ST AlzeCure Pharma AB (publ)
1.7300
+4.85%
SNSE Sensei Biotherapeutics, Inc.
0.4628
+2.01%
WSNAF Wesana Health Holdings Inc.
0.0900
-18.18%